Results of chemotherapy are presented in detail for 603 courses of therapy with 30 drugs in 400 consecutive patients with 22 types of solid tumors. An overall response rate of 20% was observed. The length of response and length of survival was surprisingly short, even in patients who were treated on an adjuvant basis following potentially curative surgery for tumors with poor prognosis. Although chemotherapy provides encouragement and temporary improvement for many patients, and long-term objective benefit for a few, substantial improvement in drugs and methods is needed to provide useful, long-term benefit for the majority of patients with solid tumors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.